NCT05238506View on ClinicalTrials.gov

Lidocaine VS Hemodynamic, Metabolic and Hormonal Response

PHASE4CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

March 12, 2022

Primary Completion Date

August 8, 2023

Study Completion Date

August 8, 2023

Conditions
Hemodynamic ResponseAcute AppendicitisComplication of TreatmentOpioid ConsumptionPneumoperitoneum
Interventions
DRUG

Intravenous lidocaine

Intraoperative intravenous lidocaine infusion.

DRUG

Normal saline infusion

Intraoperative intravenous normal saline infusion.

Trial Locations (1)

02-091

University Clinic Centre of Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER